Cancers | Free Full-Text | STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma | HTML
Welcome to Scientific Archives | A Brief Update on STAT3 Signaling: Current Challenges and Future Directions in Cancer Treatment
STAT3 inhibitors tested in clinical trials for solid tumors. | Download Scientific Diagram
Novel activators and small-molecule inhibitors of STAT3 in cancer - ScienceDirect
Targeting STAT3 in Cancer Immunotherapy | Molecular Cancer | Full Text
STAT3 Inhibitors in Clinical Trials | Download Table
Cancers | Free Full-Text | Targeting STAT3 in Cancer with Nucleotide Therapeutics | HTML
Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
IJMS | Free Full-Text | Targeting the JAK2/STAT3 Pathway—Can We Compare It to the Two Faces of the God Janus? | HTML
STAT3 Inhibitors in Clinical Trials | Download Table
Novel activators and small-molecule inhibitors of STAT3 in cancer - ScienceDirect
Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer | OTT
Targeting STAT3 in Cancer Immunotherapy | Molecular Cancer | Full Text
Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma | PLOS ONE
RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy | Cell Death & Disease
Approaching non-canonical STAT3 signaling to redefine cancer therapeutic strategy
STAT3 and its targeting inhibitors in osteosarcoma - Liu - 2021 - Cell Proliferation - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3) inhibitors... | Download Table
STAT3 Inhibitors in Clinical Trials | Download Table
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review | Journal of Experimental & Clinical Cancer Research | Full Text
Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity | Cell Death & Disease
STAT3 Inhibitors in Clinical Trials | Download Table
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation | Journal of Medicinal Chemistry
STAT3 as an emerging molecular target in pancreatic cancer | GICTT
